Global Dry Powder Inhalation Device Market Growth 2026-2032
The global Dry Powder Inhalation Device market size is predicted to grow from US$ 1654 million in 2025 to US$ 2677 million in 2032; it is expected to grow at a CAGR of 7.3% from 2026 to 2032.
A dry powder inhalation device is a medical device that drives drug powder into the respiratory tract through the patient's active inhalation. Its core design concept is to use the patient's own respiratory airflow to achieve drug delivery without propellant.
Market Concentration and Key Players:
Internationally, the market concentration of dry powder inhalers is relatively high, mainly concentrated on Europe, America and other developed countries. For example, large manufacturers such as GSK, AstraZeneca and Boehringer Ingelheim; from the domestic perspective, dry powder inhalers still have great development space in China.
Manufacturing Process and Market Trends:
The manufacturing process of dry powder inhalers revolves around drug micronization, carrier optimization and device design. The core processes include jet milling, spray drying and supercritical fluid technology, among which the new spray freeze-drying method forms amorphous powder through rapid solidification at low temperature, and combines with reverse gas chromatography to accurately control the surface energy and humidity sensitivity of the powder. The particle size of micronized drug needs to be controlled within 1-5?m to optimize lung deposition. Carriers such as lactose solve the agglomeration problem through electrostatic repulsion and anti-condensation design. The multi-dose reservoir device adopts intelligent filling line to realize efficient production of 100,000 vials per hour. For example, the Ellipta inhaler synchronizes blister foil peeling with dose counting through a precision mechanical structure, ensuring a delivered dose error rate of less than 5%.
At the market level, the global and China share increased. Drivers include a chronic obstructive pulmonary disease patient base of more than 350 million patients, an increased proportion of biologics delivery demand, and intelligent devices integrated with sensors to monitor medication compliance. In terms of technical trend, flexible electronics and 3D printing are integrated to develop curved atomizing nozzle, the detection sensitivity of graphene sensor is improved, and degradable materials reduce environmental burden. At the policy end, China has included 4 types of inhalants into medical insurance through centralized procurement policy to accelerate the process of domestic substitution, such as breaking the import monopoly of healthy budesonide suspension. In the regional market, Southeast Asia shows a super-high growth rate due to the increase of medical investment, becoming a new focus of international pharmaceutical enterprise layout.
LP Information, Inc. (LPI) ' newest research report, the ?Dry Powder Inhalation Device Industry Forecast? looks at past sales and reviews total world Dry Powder Inhalation Device sales in 2025, providing a comprehensive analysis by region and market sector of projected Dry Powder Inhalation Device sales for 2026 through 2032. With Dry Powder Inhalation Device sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Dry Powder Inhalation Device industry.
This Insight Report provides a comprehensive analysis of the global Dry Powder Inhalation Device landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Dry Powder Inhalation Device portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Dry Powder Inhalation Device market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Dry Powder Inhalation Device and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Dry Powder Inhalation Device.
This report presents a comprehensive overview, market shares, and growth opportunities of Dry Powder Inhalation Device market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
A dry powder inhalation device is a medical device that drives drug powder into the respiratory tract through the patient's active inhalation. Its core design concept is to use the patient's own respiratory airflow to achieve drug delivery without propellant.
Market Concentration and Key Players:
Internationally, the market concentration of dry powder inhalers is relatively high, mainly concentrated on Europe, America and other developed countries. For example, large manufacturers such as GSK, AstraZeneca and Boehringer Ingelheim; from the domestic perspective, dry powder inhalers still have great development space in China.
Manufacturing Process and Market Trends:
The manufacturing process of dry powder inhalers revolves around drug micronization, carrier optimization and device design. The core processes include jet milling, spray drying and supercritical fluid technology, among which the new spray freeze-drying method forms amorphous powder through rapid solidification at low temperature, and combines with reverse gas chromatography to accurately control the surface energy and humidity sensitivity of the powder. The particle size of micronized drug needs to be controlled within 1-5?m to optimize lung deposition. Carriers such as lactose solve the agglomeration problem through electrostatic repulsion and anti-condensation design. The multi-dose reservoir device adopts intelligent filling line to realize efficient production of 100,000 vials per hour. For example, the Ellipta inhaler synchronizes blister foil peeling with dose counting through a precision mechanical structure, ensuring a delivered dose error rate of less than 5%.
At the market level, the global and China share increased. Drivers include a chronic obstructive pulmonary disease patient base of more than 350 million patients, an increased proportion of biologics delivery demand, and intelligent devices integrated with sensors to monitor medication compliance. In terms of technical trend, flexible electronics and 3D printing are integrated to develop curved atomizing nozzle, the detection sensitivity of graphene sensor is improved, and degradable materials reduce environmental burden. At the policy end, China has included 4 types of inhalants into medical insurance through centralized procurement policy to accelerate the process of domestic substitution, such as breaking the import monopoly of healthy budesonide suspension. In the regional market, Southeast Asia shows a super-high growth rate due to the increase of medical investment, becoming a new focus of international pharmaceutical enterprise layout.
LP Information, Inc. (LPI) ' newest research report, the ?Dry Powder Inhalation Device Industry Forecast? looks at past sales and reviews total world Dry Powder Inhalation Device sales in 2025, providing a comprehensive analysis by region and market sector of projected Dry Powder Inhalation Device sales for 2026 through 2032. With Dry Powder Inhalation Device sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Dry Powder Inhalation Device industry.
This Insight Report provides a comprehensive analysis of the global Dry Powder Inhalation Device landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Dry Powder Inhalation Device portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Dry Powder Inhalation Device market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Dry Powder Inhalation Device and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Dry Powder Inhalation Device.
This report presents a comprehensive overview, market shares, and growth opportunities of Dry Powder Inhalation Device market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Single Dose
- Multiple Doses
- Storage Type
- Asthmatic
- COPD
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Catalent
- AptarGroup
- H&T Presspart
- Vectura Delivery Devices
- MannKind Corporation
- MicroDose Therapeutx
- GSK
- Novartis
- AstraZeneca
- Boehringer Ingelheim
- Orion Pharma
- ?Liquidia Technologies?
- ?Teva Pharmaceutical Industries?
- Chiesi??
- Hovione
- Nemera
- D?rr
- Shanghai Huarui
- Hangzhou Changxi Pharmaceutical
- Suzhou Inha Medicine
- Shenzhen Resproly Biopharmaceuticals
- What is the 10-year outlook for the global Dry Powder Inhalation Device market?
- What factors are driving Dry Powder Inhalation Device market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Dry Powder Inhalation Device market opportunities vary by end market size?
- How does Dry Powder Inhalation Device break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Dry Powder Inhalation Device Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Dry Powder Inhalation Device by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Dry Powder Inhalation Device by Country/Region, 2021, 2025 & 2032
2.2 Dry Powder Inhalation Device Segment by Type
2.2.1 Single Dose
2.2.2 Multiple Doses
2.2.3 Storage Type
2.2.4 Dry Powder Inhalation Device Sales by Type
2.2.4.1 Global Dry Powder Inhalation Device Sales Market Share by Type (2021-2026)
2.2.4.2 Global Dry Powder Inhalation Device Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Dry Powder Inhalation Device Sale Price by Type (2021-2026)
2.3 Dry Powder Inhalation Device Segment by Application
2.3.1 Asthmatic
2.3.2 COPD
2.3.3 Other
2.3.4 Dry Powder Inhalation Device Sales by Application
2.3.4.1 Global Dry Powder Inhalation Device Sale Market Share by Application (2021-2026)
2.3.4.2 Global Dry Powder Inhalation Device Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Dry Powder Inhalation Device Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Dry Powder Inhalation Device Breakdown Data by Company
3.1.1 Global Dry Powder Inhalation Device Annual Sales by Company (2021-2026)
3.1.2 Global Dry Powder Inhalation Device Sales Market Share by Company (2021-2026)
3.2 Global Dry Powder Inhalation Device Annual Revenue by Company (2021-2026)
3.2.1 Global Dry Powder Inhalation Device Revenue by Company (2021-2026)
3.2.2 Global Dry Powder Inhalation Device Revenue Market Share by Company (2021-2026)
3.3 Global Dry Powder Inhalation Device Sale Price by Company
3.4 Key Manufacturers Dry Powder Inhalation Device Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Dry Powder Inhalation Device Product Location Distribution
3.4.2 Players Dry Powder Inhalation Device Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR DRY POWDER INHALATION DEVICE BY GEOGRAPHIC REGION
4.1 World Historic Dry Powder Inhalation Device Market Size by Geographic Region (2021-2026)
4.1.1 Global Dry Powder Inhalation Device Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Dry Powder Inhalation Device Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Dry Powder Inhalation Device Market Size by Country/Region (2021-2026)
4.2.1 Global Dry Powder Inhalation Device Annual Sales by Country/Region (2021-2026)
4.2.2 Global Dry Powder Inhalation Device Annual Revenue by Country/Region (2021-2026)
4.3 Americas Dry Powder Inhalation Device Sales Growth
4.4 APAC Dry Powder Inhalation Device Sales Growth
4.5 Europe Dry Powder Inhalation Device Sales Growth
4.6 Middle East & Africa Dry Powder Inhalation Device Sales Growth
5 AMERICAS
5.1 Americas Dry Powder Inhalation Device Sales by Country
5.1.1 Americas Dry Powder Inhalation Device Sales by Country (2021-2026)
5.1.2 Americas Dry Powder Inhalation Device Revenue by Country (2021-2026)
5.2 Americas Dry Powder Inhalation Device Sales by Type (2021-2026)
5.3 Americas Dry Powder Inhalation Device Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Dry Powder Inhalation Device Sales by Region
6.1.1 APAC Dry Powder Inhalation Device Sales by Region (2021-2026)
6.1.2 APAC Dry Powder Inhalation Device Revenue by Region (2021-2026)
6.2 APAC Dry Powder Inhalation Device Sales by Type (2021-2026)
6.3 APAC Dry Powder Inhalation Device Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Dry Powder Inhalation Device by Country
7.1.1 Europe Dry Powder Inhalation Device Sales by Country (2021-2026)
7.1.2 Europe Dry Powder Inhalation Device Revenue by Country (2021-2026)
7.2 Europe Dry Powder Inhalation Device Sales by Type (2021-2026)
7.3 Europe Dry Powder Inhalation Device Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Dry Powder Inhalation Device by Country
8.1.1 Middle East & Africa Dry Powder Inhalation Device Sales by Country (2021-2026)
8.1.2 Middle East & Africa Dry Powder Inhalation Device Revenue by Country (2021-2026)
8.2 Middle East & Africa Dry Powder Inhalation Device Sales by Type (2021-2026)
8.3 Middle East & Africa Dry Powder Inhalation Device Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Dry Powder Inhalation Device
10.3 Manufacturing Process Analysis of Dry Powder Inhalation Device
10.4 Industry Chain Structure of Dry Powder Inhalation Device
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Dry Powder Inhalation Device Distributors
11.3 Dry Powder Inhalation Device Customer
12 WORLD FORECAST REVIEW FOR DRY POWDER INHALATION DEVICE BY GEOGRAPHIC REGION
12.1 Global Dry Powder Inhalation Device Market Size Forecast by Region
12.1.1 Global Dry Powder Inhalation Device Forecast by Region (2027-2032)
12.1.2 Global Dry Powder Inhalation Device Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Dry Powder Inhalation Device Forecast by Type (2027-2032)
12.7 Global Dry Powder Inhalation Device Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Catalent
13.1.1 Catalent Company Information
13.1.2 Catalent Dry Powder Inhalation Device Product Portfolios and Specifications
13.1.3 Catalent Dry Powder Inhalation Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Catalent Main Business Overview
13.1.5 Catalent Latest Developments
13.2 AptarGroup
13.2.1 AptarGroup Company Information
13.2.2 AptarGroup Dry Powder Inhalation Device Product Portfolios and Specifications
13.2.3 AptarGroup Dry Powder Inhalation Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 AptarGroup Main Business Overview
13.2.5 AptarGroup Latest Developments
13.3 H&T Presspart
13.3.1 H&T Presspart Company Information
13.3.2 H&T Presspart Dry Powder Inhalation Device Product Portfolios and Specifications
13.3.3 H&T Presspart Dry Powder Inhalation Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 H&T Presspart Main Business Overview
13.3.5 H&T Presspart Latest Developments
13.4 Vectura Delivery Devices
13.4.1 Vectura Delivery Devices Company Information
13.4.2 Vectura Delivery Devices Dry Powder Inhalation Device Product Portfolios and Specifications
13.4.3 Vectura Delivery Devices Dry Powder Inhalation Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Vectura Delivery Devices Main Business Overview
13.4.5 Vectura Delivery Devices Latest Developments
13.5 MannKind Corporation
13.5.1 MannKind Corporation Company Information
13.5.2 MannKind Corporation Dry Powder Inhalation Device Product Portfolios and Specifications
13.5.3 MannKind Corporation Dry Powder Inhalation Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 MannKind Corporation Main Business Overview
13.5.5 MannKind Corporation Latest Developments
13.6 MicroDose Therapeutx
13.6.1 MicroDose Therapeutx Company Information
13.6.2 MicroDose Therapeutx Dry Powder Inhalation Device Product Portfolios and Specifications
13.6.3 MicroDose Therapeutx Dry Powder Inhalation Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 MicroDose Therapeutx Main Business Overview
13.6.5 MicroDose Therapeutx Latest Developments
13.7 GSK
13.7.1 GSK Company Information
13.7.2 GSK Dry Powder Inhalation Device Product Portfolios and Specifications
13.7.3 GSK Dry Powder Inhalation Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 GSK Main Business Overview
13.7.5 GSK Latest Developments
13.8 Novartis
13.8.1 Novartis Company Information
13.8.2 Novartis Dry Powder Inhalation Device Product Portfolios and Specifications
13.8.3 Novartis Dry Powder Inhalation Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Novartis Main Business Overview
13.8.5 Novartis Latest Developments
13.9 AstraZeneca
13.9.1 AstraZeneca Company Information
13.9.2 AstraZeneca Dry Powder Inhalation Device Product Portfolios and Specifications
13.9.3 AstraZeneca Dry Powder Inhalation Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 AstraZeneca Main Business Overview
13.9.5 AstraZeneca Latest Developments
13.10 Boehringer Ingelheim
13.10.1 Boehringer Ingelheim Company Information
13.10.2 Boehringer Ingelheim Dry Powder Inhalation Device Product Portfolios and Specifications
13.10.3 Boehringer Ingelheim Dry Powder Inhalation Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Boehringer Ingelheim Main Business Overview
13.10.5 Boehringer Ingelheim Latest Developments
13.11 Orion Pharma
13.11.1 Orion Pharma Company Information
13.11.2 Orion Pharma Dry Powder Inhalation Device Product Portfolios and Specifications
13.11.3 Orion Pharma Dry Powder Inhalation Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Orion Pharma Main Business Overview
13.11.5 Orion Pharma Latest Developments
13.12 ?Liquidia Technologies?
13.12.1 ?Liquidia Technologies? Company Information
13.12.2 ?Liquidia Technologies? Dry Powder Inhalation Device Product Portfolios and Specifications
13.12.3 ?Liquidia Technologies? Dry Powder Inhalation Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 ?Liquidia Technologies? Main Business Overview
13.12.5 ?Liquidia Technologies? Latest Developments
13.13 ?Teva Pharmaceutical Industries?
13.13.1 ?Teva Pharmaceutical Industries? Company Information
13.13.2 ?Teva Pharmaceutical Industries? Dry Powder Inhalation Device Product Portfolios and Specifications
13.13.3 ?Teva Pharmaceutical Industries? Dry Powder Inhalation Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 ?Teva Pharmaceutical Industries? Main Business Overview
13.13.5 ?Teva Pharmaceutical Industries? Latest Developments
13.14 Chiesi??
13.14.1 Chiesi?? Company Information
13.14.2 Chiesi?? Dry Powder Inhalation Device Product Portfolios and Specifications
13.14.3 Chiesi?? Dry Powder Inhalation Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Chiesi?? Main Business Overview
13.14.5 Chiesi?? Latest Developments
13.15 Hovione
13.15.1 Hovione Company Information
13.15.2 Hovione Dry Powder Inhalation Device Product Portfolios and Specifications
13.15.3 Hovione Dry Powder Inhalation Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Hovione Main Business Overview
13.15.5 Hovione Latest Developments
13.16 Nemera
13.16.1 Nemera Company Information
13.16.2 Nemera Dry Powder Inhalation Device Product Portfolios and Specifications
13.16.3 Nemera Dry Powder Inhalation Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 Nemera Main Business Overview
13.16.5 Nemera Latest Developments
13.17 D?rr
13.17.1 D?rr Company Information
13.17.2 D?rr Dry Powder Inhalation Device Product Portfolios and Specifications
13.17.3 D?rr Dry Powder Inhalation Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.17.4 D?rr Main Business Overview
13.17.5 D?rr Latest Developments
13.18 Shanghai Huarui
13.18.1 Shanghai Huarui Company Information
13.18.2 Shanghai Huarui Dry Powder Inhalation Device Product Portfolios and Specifications
13.18.3 Shanghai Huarui Dry Powder Inhalation Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.18.4 Shanghai Huarui Main Business Overview
13.18.5 Shanghai Huarui Latest Developments
13.19 Hangzhou Changxi Pharmaceutical
13.19.1 Hangzhou Changxi Pharmaceutical Company Information
13.19.2 Hangzhou Changxi Pharmaceutical Dry Powder Inhalation Device Product Portfolios and Specifications
13.19.3 Hangzhou Changxi Pharmaceutical Dry Powder Inhalation Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.19.4 Hangzhou Changxi Pharmaceutical Main Business Overview
13.19.5 Hangzhou Changxi Pharmaceutical Latest Developments
13.20 Suzhou Inha Medicine
13.20.1 Suzhou Inha Medicine Company Information
13.20.2 Suzhou Inha Medicine Dry Powder Inhalation Device Product Portfolios and Specifications
13.20.3 Suzhou Inha Medicine Dry Powder Inhalation Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.20.4 Suzhou Inha Medicine Main Business Overview
13.20.5 Suzhou Inha Medicine Latest Developments
13.21 Shenzhen Resproly Biopharmaceuticals
13.21.1 Shenzhen Resproly Biopharmaceuticals Company Information
13.21.2 Shenzhen Resproly Biopharmaceuticals Dry Powder Inhalation Device Product Portfolios and Specifications
13.21.3 Shenzhen Resproly Biopharmaceuticals Dry Powder Inhalation Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.21.4 Shenzhen Resproly Biopharmaceuticals Main Business Overview
13.21.5 Shenzhen Resproly Biopharmaceuticals Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Dry Powder Inhalation Device Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Dry Powder Inhalation Device by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Dry Powder Inhalation Device by Country/Region, 2021, 2025 & 2032
2.2 Dry Powder Inhalation Device Segment by Type
2.2.1 Single Dose
2.2.2 Multiple Doses
2.2.3 Storage Type
2.2.4 Dry Powder Inhalation Device Sales by Type
2.2.4.1 Global Dry Powder Inhalation Device Sales Market Share by Type (2021-2026)
2.2.4.2 Global Dry Powder Inhalation Device Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Dry Powder Inhalation Device Sale Price by Type (2021-2026)
2.3 Dry Powder Inhalation Device Segment by Application
2.3.1 Asthmatic
2.3.2 COPD
2.3.3 Other
2.3.4 Dry Powder Inhalation Device Sales by Application
2.3.4.1 Global Dry Powder Inhalation Device Sale Market Share by Application (2021-2026)
2.3.4.2 Global Dry Powder Inhalation Device Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Dry Powder Inhalation Device Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Dry Powder Inhalation Device Breakdown Data by Company
3.1.1 Global Dry Powder Inhalation Device Annual Sales by Company (2021-2026)
3.1.2 Global Dry Powder Inhalation Device Sales Market Share by Company (2021-2026)
3.2 Global Dry Powder Inhalation Device Annual Revenue by Company (2021-2026)
3.2.1 Global Dry Powder Inhalation Device Revenue by Company (2021-2026)
3.2.2 Global Dry Powder Inhalation Device Revenue Market Share by Company (2021-2026)
3.3 Global Dry Powder Inhalation Device Sale Price by Company
3.4 Key Manufacturers Dry Powder Inhalation Device Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Dry Powder Inhalation Device Product Location Distribution
3.4.2 Players Dry Powder Inhalation Device Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR DRY POWDER INHALATION DEVICE BY GEOGRAPHIC REGION
4.1 World Historic Dry Powder Inhalation Device Market Size by Geographic Region (2021-2026)
4.1.1 Global Dry Powder Inhalation Device Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Dry Powder Inhalation Device Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Dry Powder Inhalation Device Market Size by Country/Region (2021-2026)
4.2.1 Global Dry Powder Inhalation Device Annual Sales by Country/Region (2021-2026)
4.2.2 Global Dry Powder Inhalation Device Annual Revenue by Country/Region (2021-2026)
4.3 Americas Dry Powder Inhalation Device Sales Growth
4.4 APAC Dry Powder Inhalation Device Sales Growth
4.5 Europe Dry Powder Inhalation Device Sales Growth
4.6 Middle East & Africa Dry Powder Inhalation Device Sales Growth
5 AMERICAS
5.1 Americas Dry Powder Inhalation Device Sales by Country
5.1.1 Americas Dry Powder Inhalation Device Sales by Country (2021-2026)
5.1.2 Americas Dry Powder Inhalation Device Revenue by Country (2021-2026)
5.2 Americas Dry Powder Inhalation Device Sales by Type (2021-2026)
5.3 Americas Dry Powder Inhalation Device Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Dry Powder Inhalation Device Sales by Region
6.1.1 APAC Dry Powder Inhalation Device Sales by Region (2021-2026)
6.1.2 APAC Dry Powder Inhalation Device Revenue by Region (2021-2026)
6.2 APAC Dry Powder Inhalation Device Sales by Type (2021-2026)
6.3 APAC Dry Powder Inhalation Device Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Dry Powder Inhalation Device by Country
7.1.1 Europe Dry Powder Inhalation Device Sales by Country (2021-2026)
7.1.2 Europe Dry Powder Inhalation Device Revenue by Country (2021-2026)
7.2 Europe Dry Powder Inhalation Device Sales by Type (2021-2026)
7.3 Europe Dry Powder Inhalation Device Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Dry Powder Inhalation Device by Country
8.1.1 Middle East & Africa Dry Powder Inhalation Device Sales by Country (2021-2026)
8.1.2 Middle East & Africa Dry Powder Inhalation Device Revenue by Country (2021-2026)
8.2 Middle East & Africa Dry Powder Inhalation Device Sales by Type (2021-2026)
8.3 Middle East & Africa Dry Powder Inhalation Device Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Dry Powder Inhalation Device
10.3 Manufacturing Process Analysis of Dry Powder Inhalation Device
10.4 Industry Chain Structure of Dry Powder Inhalation Device
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Dry Powder Inhalation Device Distributors
11.3 Dry Powder Inhalation Device Customer
12 WORLD FORECAST REVIEW FOR DRY POWDER INHALATION DEVICE BY GEOGRAPHIC REGION
12.1 Global Dry Powder Inhalation Device Market Size Forecast by Region
12.1.1 Global Dry Powder Inhalation Device Forecast by Region (2027-2032)
12.1.2 Global Dry Powder Inhalation Device Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Dry Powder Inhalation Device Forecast by Type (2027-2032)
12.7 Global Dry Powder Inhalation Device Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Catalent
13.1.1 Catalent Company Information
13.1.2 Catalent Dry Powder Inhalation Device Product Portfolios and Specifications
13.1.3 Catalent Dry Powder Inhalation Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Catalent Main Business Overview
13.1.5 Catalent Latest Developments
13.2 AptarGroup
13.2.1 AptarGroup Company Information
13.2.2 AptarGroup Dry Powder Inhalation Device Product Portfolios and Specifications
13.2.3 AptarGroup Dry Powder Inhalation Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 AptarGroup Main Business Overview
13.2.5 AptarGroup Latest Developments
13.3 H&T Presspart
13.3.1 H&T Presspart Company Information
13.3.2 H&T Presspart Dry Powder Inhalation Device Product Portfolios and Specifications
13.3.3 H&T Presspart Dry Powder Inhalation Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 H&T Presspart Main Business Overview
13.3.5 H&T Presspart Latest Developments
13.4 Vectura Delivery Devices
13.4.1 Vectura Delivery Devices Company Information
13.4.2 Vectura Delivery Devices Dry Powder Inhalation Device Product Portfolios and Specifications
13.4.3 Vectura Delivery Devices Dry Powder Inhalation Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Vectura Delivery Devices Main Business Overview
13.4.5 Vectura Delivery Devices Latest Developments
13.5 MannKind Corporation
13.5.1 MannKind Corporation Company Information
13.5.2 MannKind Corporation Dry Powder Inhalation Device Product Portfolios and Specifications
13.5.3 MannKind Corporation Dry Powder Inhalation Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 MannKind Corporation Main Business Overview
13.5.5 MannKind Corporation Latest Developments
13.6 MicroDose Therapeutx
13.6.1 MicroDose Therapeutx Company Information
13.6.2 MicroDose Therapeutx Dry Powder Inhalation Device Product Portfolios and Specifications
13.6.3 MicroDose Therapeutx Dry Powder Inhalation Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 MicroDose Therapeutx Main Business Overview
13.6.5 MicroDose Therapeutx Latest Developments
13.7 GSK
13.7.1 GSK Company Information
13.7.2 GSK Dry Powder Inhalation Device Product Portfolios and Specifications
13.7.3 GSK Dry Powder Inhalation Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 GSK Main Business Overview
13.7.5 GSK Latest Developments
13.8 Novartis
13.8.1 Novartis Company Information
13.8.2 Novartis Dry Powder Inhalation Device Product Portfolios and Specifications
13.8.3 Novartis Dry Powder Inhalation Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Novartis Main Business Overview
13.8.5 Novartis Latest Developments
13.9 AstraZeneca
13.9.1 AstraZeneca Company Information
13.9.2 AstraZeneca Dry Powder Inhalation Device Product Portfolios and Specifications
13.9.3 AstraZeneca Dry Powder Inhalation Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 AstraZeneca Main Business Overview
13.9.5 AstraZeneca Latest Developments
13.10 Boehringer Ingelheim
13.10.1 Boehringer Ingelheim Company Information
13.10.2 Boehringer Ingelheim Dry Powder Inhalation Device Product Portfolios and Specifications
13.10.3 Boehringer Ingelheim Dry Powder Inhalation Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Boehringer Ingelheim Main Business Overview
13.10.5 Boehringer Ingelheim Latest Developments
13.11 Orion Pharma
13.11.1 Orion Pharma Company Information
13.11.2 Orion Pharma Dry Powder Inhalation Device Product Portfolios and Specifications
13.11.3 Orion Pharma Dry Powder Inhalation Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Orion Pharma Main Business Overview
13.11.5 Orion Pharma Latest Developments
13.12 ?Liquidia Technologies?
13.12.1 ?Liquidia Technologies? Company Information
13.12.2 ?Liquidia Technologies? Dry Powder Inhalation Device Product Portfolios and Specifications
13.12.3 ?Liquidia Technologies? Dry Powder Inhalation Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 ?Liquidia Technologies? Main Business Overview
13.12.5 ?Liquidia Technologies? Latest Developments
13.13 ?Teva Pharmaceutical Industries?
13.13.1 ?Teva Pharmaceutical Industries? Company Information
13.13.2 ?Teva Pharmaceutical Industries? Dry Powder Inhalation Device Product Portfolios and Specifications
13.13.3 ?Teva Pharmaceutical Industries? Dry Powder Inhalation Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 ?Teva Pharmaceutical Industries? Main Business Overview
13.13.5 ?Teva Pharmaceutical Industries? Latest Developments
13.14 Chiesi??
13.14.1 Chiesi?? Company Information
13.14.2 Chiesi?? Dry Powder Inhalation Device Product Portfolios and Specifications
13.14.3 Chiesi?? Dry Powder Inhalation Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Chiesi?? Main Business Overview
13.14.5 Chiesi?? Latest Developments
13.15 Hovione
13.15.1 Hovione Company Information
13.15.2 Hovione Dry Powder Inhalation Device Product Portfolios and Specifications
13.15.3 Hovione Dry Powder Inhalation Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Hovione Main Business Overview
13.15.5 Hovione Latest Developments
13.16 Nemera
13.16.1 Nemera Company Information
13.16.2 Nemera Dry Powder Inhalation Device Product Portfolios and Specifications
13.16.3 Nemera Dry Powder Inhalation Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 Nemera Main Business Overview
13.16.5 Nemera Latest Developments
13.17 D?rr
13.17.1 D?rr Company Information
13.17.2 D?rr Dry Powder Inhalation Device Product Portfolios and Specifications
13.17.3 D?rr Dry Powder Inhalation Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.17.4 D?rr Main Business Overview
13.17.5 D?rr Latest Developments
13.18 Shanghai Huarui
13.18.1 Shanghai Huarui Company Information
13.18.2 Shanghai Huarui Dry Powder Inhalation Device Product Portfolios and Specifications
13.18.3 Shanghai Huarui Dry Powder Inhalation Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.18.4 Shanghai Huarui Main Business Overview
13.18.5 Shanghai Huarui Latest Developments
13.19 Hangzhou Changxi Pharmaceutical
13.19.1 Hangzhou Changxi Pharmaceutical Company Information
13.19.2 Hangzhou Changxi Pharmaceutical Dry Powder Inhalation Device Product Portfolios and Specifications
13.19.3 Hangzhou Changxi Pharmaceutical Dry Powder Inhalation Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.19.4 Hangzhou Changxi Pharmaceutical Main Business Overview
13.19.5 Hangzhou Changxi Pharmaceutical Latest Developments
13.20 Suzhou Inha Medicine
13.20.1 Suzhou Inha Medicine Company Information
13.20.2 Suzhou Inha Medicine Dry Powder Inhalation Device Product Portfolios and Specifications
13.20.3 Suzhou Inha Medicine Dry Powder Inhalation Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.20.4 Suzhou Inha Medicine Main Business Overview
13.20.5 Suzhou Inha Medicine Latest Developments
13.21 Shenzhen Resproly Biopharmaceuticals
13.21.1 Shenzhen Resproly Biopharmaceuticals Company Information
13.21.2 Shenzhen Resproly Biopharmaceuticals Dry Powder Inhalation Device Product Portfolios and Specifications
13.21.3 Shenzhen Resproly Biopharmaceuticals Dry Powder Inhalation Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.21.4 Shenzhen Resproly Biopharmaceuticals Main Business Overview
13.21.5 Shenzhen Resproly Biopharmaceuticals Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Dry Powder Inhalation Device Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Dry Powder Inhalation Device Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Single Dose
Table 4. Major Players of Multiple Doses
Table 5. Major Players of Storage Type
Table 6. Global Dry Powder Inhalation Device Sales by Type (2021-2026) & (K Units)
Table 7. Global Dry Powder Inhalation Device Sales Market Share by Type (2021-2026)
Table 8. Global Dry Powder Inhalation Device Revenue by Type (2021-2026) & ($ million)
Table 9. Global Dry Powder Inhalation Device Revenue Market Share by Type (2021-2026)
Table 10. Global Dry Powder Inhalation Device Sale Price by Type (2021-2026) & (US$/Unit)
Table 11. Global Dry Powder Inhalation Device Sale by Application (2021-2026) & (K Units)
Table 12. Global Dry Powder Inhalation Device Sale Market Share by Application (2021-2026)
Table 13. Global Dry Powder Inhalation Device Revenue by Application (2021-2026) & ($ million)
Table 14. Global Dry Powder Inhalation Device Revenue Market Share by Application (2021-2026)
Table 15. Global Dry Powder Inhalation Device Sale Price by Application (2021-2026) & (US$/Unit)
Table 16. Global Dry Powder Inhalation Device Sales by Company (2021-2026) & (K Units)
Table 17. Global Dry Powder Inhalation Device Sales Market Share by Company (2021-2026)
Table 18. Global Dry Powder Inhalation Device Revenue by Company (2021-2026) & ($ millions)
Table 19. Global Dry Powder Inhalation Device Revenue Market Share by Company (2021-2026)
Table 20. Global Dry Powder Inhalation Device Sale Price by Company (2021-2026) & (US$/Unit)
Table 21. Key Manufacturers Dry Powder Inhalation Device Producing Area Distribution and Sales Area
Table 22. Players Dry Powder Inhalation Device Products Offered
Table 23. Dry Powder Inhalation Device Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Dry Powder Inhalation Device Sales by Geographic Region (2021-2026) & (K Units)
Table 27. Global Dry Powder Inhalation Device Sales Market Share Geographic Region (2021-2026)
Table 28. Global Dry Powder Inhalation Device Revenue by Geographic Region (2021-2026) & ($ millions)
Table 29. Global Dry Powder Inhalation Device Revenue Market Share by Geographic Region (2021-2026)
Table 30. Global Dry Powder Inhalation Device Sales by Country/Region (2021-2026) & (K Units)
Table 31. Global Dry Powder Inhalation Device Sales Market Share by Country/Region (2021-2026)
Table 32. Global Dry Powder Inhalation Device Revenue by Country/Region (2021-2026) & ($ millions)
Table 33. Global Dry Powder Inhalation Device Revenue Market Share by Country/Region (2021-2026)
Table 34. Americas Dry Powder Inhalation Device Sales by Country (2021-2026) & (K Units)
Table 35. Americas Dry Powder Inhalation Device Sales Market Share by Country (2021-2026)
Table 36. Americas Dry Powder Inhalation Device Revenue by Country (2021-2026) & ($ millions)
Table 37. Americas Dry Powder Inhalation Device Sales by Type (2021-2026) & (K Units)
Table 38. Americas Dry Powder Inhalation Device Sales by Application (2021-2026) & (K Units)
Table 39. APAC Dry Powder Inhalation Device Sales by Region (2021-2026) & (K Units)
Table 40. APAC Dry Powder Inhalation Device Sales Market Share by Region (2021-2026)
Table 41. APAC Dry Powder Inhalation Device Revenue by Region (2021-2026) & ($ millions)
Table 42. APAC Dry Powder Inhalation Device Sales by Type (2021-2026) & (K Units)
Table 43. APAC Dry Powder Inhalation Device Sales by Application (2021-2026) & (K Units)
Table 44. Europe Dry Powder Inhalation Device Sales by Country (2021-2026) & (K Units)
Table 45. Europe Dry Powder Inhalation Device Revenue by Country (2021-2026) & ($ millions)
Table 46. Europe Dry Powder Inhalation Device Sales by Type (2021-2026) & (K Units)
Table 47. Europe Dry Powder Inhalation Device Sales by Application (2021-2026) & (K Units)
Table 48. Middle East & Africa Dry Powder Inhalation Device Sales by Country (2021-2026) & (K Units)
Table 49. Middle East & Africa Dry Powder Inhalation Device Revenue Market Share by Country (2021-2026)
Table 50. Middle East & Africa Dry Powder Inhalation Device Sales by Type (2021-2026) & (K Units)
Table 51. Middle East & Africa Dry Powder Inhalation Device Sales by Application (2021-2026) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of Dry Powder Inhalation Device
Table 53. Key Market Challenges & Risks of Dry Powder Inhalation Device
Table 54. Key Industry Trends of Dry Powder Inhalation Device
Table 55. Dry Powder Inhalation Device Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Dry Powder Inhalation Device Distributors List
Table 58. Dry Powder Inhalation Device Customer List
Table 59. Global Dry Powder Inhalation Device Sales Forecast by Region (2027-2032) & (K Units)
Table 60. Global Dry Powder Inhalation Device Revenue Forecast by Region (2027-2032) & ($ millions)
Table 61. Americas Dry Powder Inhalation Device Sales Forecast by Country (2027-2032) & (K Units)
Table 62. Americas Dry Powder Inhalation Device Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 63. APAC Dry Powder Inhalation Device Sales Forecast by Region (2027-2032) & (K Units)
Table 64. APAC Dry Powder Inhalation Device Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 65. Europe Dry Powder Inhalation Device Sales Forecast by Country (2027-2032) & (K Units)
Table 66. Europe Dry Powder Inhalation Device Revenue Forecast by Country (2027-2032) & ($ millions)
Table 67. Middle East & Africa Dry Powder Inhalation Device Sales Forecast by Country (2027-2032) & (K Units)
Table 68. Middle East & Africa Dry Powder Inhalation Device Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Global Dry Powder Inhalation Device Sales Forecast by Type (2027-2032) & (K Units)
Table 70. Global Dry Powder Inhalation Device Revenue Forecast by Type (2027-2032) & ($ millions)
Table 71. Global Dry Powder Inhalation Device Sales Forecast by Application (2027-2032) & (K Units)
Table 72. Global Dry Powder Inhalation Device Revenue Forecast by Application (2027-2032) & ($ millions)
Table 73. Catalent Basic Information, Dry Powder Inhalation Device Manufacturing Base, Sales Area and Its Competitors
Table 74. Catalent Dry Powder Inhalation Device Product Portfolios and Specifications
Table 75. Catalent Dry Powder Inhalation Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 76. Catalent Main Business
Table 77. Catalent Latest Developments
Table 78. AptarGroup Basic Information, Dry Powder Inhalation Device Manufacturing Base, Sales Area and Its Competitors
Table 79. AptarGroup Dry Powder Inhalation Device Product Portfolios and Specifications
Table 80. AptarGroup Dry Powder Inhalation Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 81. AptarGroup Main Business
Table 82. AptarGroup Latest Developments
Table 83. H&T Presspart Basic Information, Dry Powder Inhalation Device Manufacturing Base, Sales Area and Its Competitors
Table 84. H&T Presspart Dry Powder Inhalation Device Product Portfolios and Specifications
Table 85. H&T Presspart Dry Powder Inhalation Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 86. H&T Presspart Main Business
Table 87. H&T Presspart Latest Developments
Table 88. Vectura Delivery Devices Basic Information, Dry Powder Inhalation Device Manufacturing Base, Sales Area and Its Competitors
Table 89. Vectura Delivery Devices Dry Powder Inhalation Device Product Portfolios and Specifications
Table 90. Vectura Delivery Devices Dry Powder Inhalation Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 91. Vectura Delivery Devices Main Business
Table 92. Vectura Delivery Devices Latest Developments
Table 93. MannKind Corporation Basic Information, Dry Powder Inhalation Device Manufacturing Base, Sales Area and Its Competitors
Table 94. MannKind Corporation Dry Powder Inhalation Device Product Portfolios and Specifications
Table 95. MannKind Corporation Dry Powder Inhalation Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 96. MannKind Corporation Main Business
Table 97. MannKind Corporation Latest Developments
Table 98. MicroDose Therapeutx Basic Information, Dry Powder Inhalation Device Manufacturing Base, Sales Area and Its Competitors
Table 99. MicroDose Therapeutx Dry Powder Inhalation Device Product Portfolios and Specifications
Table 100. MicroDose Therapeutx Dry Powder Inhalation Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 101. MicroDose Therapeutx Main Business
Table 102. MicroDose Therapeutx Latest Developments
Table 103. GSK Basic Information, Dry Powder Inhalation Device Manufacturing Base, Sales Area and Its Competitors
Table 104. GSK Dry Powder Inhalation Device Product Portfolios and Specifications
Table 105. GSK Dry Powder Inhalation Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 106. GSK Main Business
Table 107. GSK Latest Developments
Table 108. Novartis Basic Information, Dry Powder Inhalation Device Manufacturing Base, Sales Area and Its Competitors
Table 109. Novartis Dry Powder Inhalation Device Product Portfolios and Specifications
Table 110. Novartis Dry Powder Inhalation Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 111. Novartis Main Business
Table 112. Novartis Latest Developments
Table 113. AstraZeneca Basic Information, Dry Powder Inhalation Device Manufacturing Base, Sales Area and Its Competitors
Table 114. AstraZeneca Dry Powder Inhalation Device Product Portfolios and Specifications
Table 115. AstraZeneca Dry Powder Inhalation Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 116. AstraZeneca Main Business
Table 117. AstraZeneca Latest Developments
Table 118. Boehringer Ingelheim Basic Information, Dry Powder Inhalation Device Manufacturing Base, Sales Area and Its Competitors
Table 119. Boehringer Ingelheim Dry Powder Inhalation Device Product Portfolios and Specifications
Table 120. Boehringer Ingelheim Dry Powder Inhalation Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 121. Boehringer Ingelheim Main Business
Table 122. Boehringer Ingelheim Latest Developments
Table 123. Orion Pharma Basic Information, Dry Powder Inhalation Device Manufacturing Base, Sales Area and Its Competitors
Table 124. Orion Pharma Dry Powder Inhalation Device Product Portfolios and Specifications
Table 125. Orion Pharma Dry Powder Inhalation Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 126. Orion Pharma Main Business
Table 127. Orion Pharma Latest Developments
Table 128. ?Liquidia Technologies? Basic Information, Dry Powder Inhalation Device Manufacturing Base, Sales Area and Its Competitors
Table 129. ?Liquidia Technologies? Dry Powder Inhalation Device Product Portfolios and Specifications
Table 130. ?Liquidia Technologies? Dry Powder Inhalation Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 131. ?Liquidia Technologies? Main Business
Table 132. ?Liquidia Technologies? Latest Developments
Table 133. ?Teva Pharmaceutical Industries? Basic Information, Dry Powder Inhalation Device Manufacturing Base, Sales Area and Its Competitors
Table 134. ?Teva Pharmaceutical Industries? Dry Powder Inhalation Device Product Portfolios and Specifications
Table 135. ?Teva Pharmaceutical Industries? Dry Powder Inhalation Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 136. ?Teva Pharmaceutical Industries? Main Business
Table 137. ?Teva Pharmaceutical Industries? Latest Developments
Table 138. Chiesi?? Basic Information, Dry Powder Inhalation Device Manufacturing Base, Sales Area and Its Competitors
Table 139. Chiesi?? Dry Powder Inhalation Device Product Portfolios and Specifications
Table 140. Chiesi?? Dry Powder Inhalation Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 141. Chiesi?? Main Business
Table 142. Chiesi?? Latest Developments
Table 143. Hovione Basic Information, Dry Powder Inhalation Device Manufacturing Base, Sales Area and Its Competitors
Table 144. Hovione Dry Powder Inhalation Device Product Portfolios and Specifications
Table 145. Hovione Dry Powder Inhalation Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 146. Hovione Main Business
Table 147. Hovione Latest Developments
Table 148. Nemera Basic Information, Dry Powder Inhalation Device Manufacturing Base, Sales Area and Its Competitors
Table 149. Nemera Dry Powder Inhalation Device Product Portfolios and Specifications
Table 150. Nemera Dry Powder Inhalation Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 151. Nemera Main Business
Table 152. Nemera Latest Developments
Table 153. D?rr Basic Information, Dry Powder Inhalation Device Manufacturing Base, Sales Area and Its Competitors
Table 154. D?rr Dry Powder Inhalation Device Product Portfolios and Specifications
Table 155. D?rr Dry Powder Inhalation Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 156. D?rr Main Business
Table 157. D?rr Latest Developments
Table 158. Shanghai Huarui Basic Information, Dry Powder Inhalation Device Manufacturing Base, Sales Area and Its Competitors
Table 159. Shanghai Huarui Dry Powder Inhalation Device Product Portfolios and Specifications
Table 160. Shanghai Huarui Dry Powder Inhalation Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 161. Shanghai Huarui Main Business
Table 162. Shanghai Huarui Latest Developments
Table 163. Hangzhou Changxi Pharmaceutical Basic Information, Dry Powder Inhalation Device Manufacturing Base, Sales Area and Its Competitors
Table 164. Hangzhou Changxi Pharmaceutical Dry Powder Inhalation Device Product Portfolios and Specifications
Table 165. Hangzhou Changxi Pharmaceutical Dry Powder Inhalation Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 166. Hangzhou Changxi Pharmaceutical Main Business
Table 167. Hangzhou Changxi Pharmaceutical Latest Developments
Table 168. Suzhou Inha Medicine Basic Information, Dry Powder Inhalation Device Manufacturing Base, Sales Area and Its Competitors
Table 169. Suzhou Inha Medicine Dry Powder Inhalation Device Product Portfolios and Specifications
Table 170. Suzhou Inha Medicine Dry Powder Inhalation Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 171. Suzhou Inha Medicine Main Business
Table 172. Suzhou Inha Medicine Latest Developments
Table 173. Shenzhen Resproly Biopharmaceuticals Basic Information, Dry Powder Inhalation Device Manufacturing Base, Sales Area and Its Competitors
Table 174. Shenzhen Resproly Biopharmaceuticals Dry Powder Inhalation Device Product Portfolios and Specifications
Table 175. Shenzhen Resproly Biopharmaceuticals Dry Powder Inhalation Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 176. Shenzhen Resproly Biopharmaceuticals Main Business
Table 177. Shenzhen Resproly Biopharmaceuticals Latest Developments
Table 1. Dry Powder Inhalation Device Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Dry Powder Inhalation Device Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Single Dose
Table 4. Major Players of Multiple Doses
Table 5. Major Players of Storage Type
Table 6. Global Dry Powder Inhalation Device Sales by Type (2021-2026) & (K Units)
Table 7. Global Dry Powder Inhalation Device Sales Market Share by Type (2021-2026)
Table 8. Global Dry Powder Inhalation Device Revenue by Type (2021-2026) & ($ million)
Table 9. Global Dry Powder Inhalation Device Revenue Market Share by Type (2021-2026)
Table 10. Global Dry Powder Inhalation Device Sale Price by Type (2021-2026) & (US$/Unit)
Table 11. Global Dry Powder Inhalation Device Sale by Application (2021-2026) & (K Units)
Table 12. Global Dry Powder Inhalation Device Sale Market Share by Application (2021-2026)
Table 13. Global Dry Powder Inhalation Device Revenue by Application (2021-2026) & ($ million)
Table 14. Global Dry Powder Inhalation Device Revenue Market Share by Application (2021-2026)
Table 15. Global Dry Powder Inhalation Device Sale Price by Application (2021-2026) & (US$/Unit)
Table 16. Global Dry Powder Inhalation Device Sales by Company (2021-2026) & (K Units)
Table 17. Global Dry Powder Inhalation Device Sales Market Share by Company (2021-2026)
Table 18. Global Dry Powder Inhalation Device Revenue by Company (2021-2026) & ($ millions)
Table 19. Global Dry Powder Inhalation Device Revenue Market Share by Company (2021-2026)
Table 20. Global Dry Powder Inhalation Device Sale Price by Company (2021-2026) & (US$/Unit)
Table 21. Key Manufacturers Dry Powder Inhalation Device Producing Area Distribution and Sales Area
Table 22. Players Dry Powder Inhalation Device Products Offered
Table 23. Dry Powder Inhalation Device Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Dry Powder Inhalation Device Sales by Geographic Region (2021-2026) & (K Units)
Table 27. Global Dry Powder Inhalation Device Sales Market Share Geographic Region (2021-2026)
Table 28. Global Dry Powder Inhalation Device Revenue by Geographic Region (2021-2026) & ($ millions)
Table 29. Global Dry Powder Inhalation Device Revenue Market Share by Geographic Region (2021-2026)
Table 30. Global Dry Powder Inhalation Device Sales by Country/Region (2021-2026) & (K Units)
Table 31. Global Dry Powder Inhalation Device Sales Market Share by Country/Region (2021-2026)
Table 32. Global Dry Powder Inhalation Device Revenue by Country/Region (2021-2026) & ($ millions)
Table 33. Global Dry Powder Inhalation Device Revenue Market Share by Country/Region (2021-2026)
Table 34. Americas Dry Powder Inhalation Device Sales by Country (2021-2026) & (K Units)
Table 35. Americas Dry Powder Inhalation Device Sales Market Share by Country (2021-2026)
Table 36. Americas Dry Powder Inhalation Device Revenue by Country (2021-2026) & ($ millions)
Table 37. Americas Dry Powder Inhalation Device Sales by Type (2021-2026) & (K Units)
Table 38. Americas Dry Powder Inhalation Device Sales by Application (2021-2026) & (K Units)
Table 39. APAC Dry Powder Inhalation Device Sales by Region (2021-2026) & (K Units)
Table 40. APAC Dry Powder Inhalation Device Sales Market Share by Region (2021-2026)
Table 41. APAC Dry Powder Inhalation Device Revenue by Region (2021-2026) & ($ millions)
Table 42. APAC Dry Powder Inhalation Device Sales by Type (2021-2026) & (K Units)
Table 43. APAC Dry Powder Inhalation Device Sales by Application (2021-2026) & (K Units)
Table 44. Europe Dry Powder Inhalation Device Sales by Country (2021-2026) & (K Units)
Table 45. Europe Dry Powder Inhalation Device Revenue by Country (2021-2026) & ($ millions)
Table 46. Europe Dry Powder Inhalation Device Sales by Type (2021-2026) & (K Units)
Table 47. Europe Dry Powder Inhalation Device Sales by Application (2021-2026) & (K Units)
Table 48. Middle East & Africa Dry Powder Inhalation Device Sales by Country (2021-2026) & (K Units)
Table 49. Middle East & Africa Dry Powder Inhalation Device Revenue Market Share by Country (2021-2026)
Table 50. Middle East & Africa Dry Powder Inhalation Device Sales by Type (2021-2026) & (K Units)
Table 51. Middle East & Africa Dry Powder Inhalation Device Sales by Application (2021-2026) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of Dry Powder Inhalation Device
Table 53. Key Market Challenges & Risks of Dry Powder Inhalation Device
Table 54. Key Industry Trends of Dry Powder Inhalation Device
Table 55. Dry Powder Inhalation Device Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Dry Powder Inhalation Device Distributors List
Table 58. Dry Powder Inhalation Device Customer List
Table 59. Global Dry Powder Inhalation Device Sales Forecast by Region (2027-2032) & (K Units)
Table 60. Global Dry Powder Inhalation Device Revenue Forecast by Region (2027-2032) & ($ millions)
Table 61. Americas Dry Powder Inhalation Device Sales Forecast by Country (2027-2032) & (K Units)
Table 62. Americas Dry Powder Inhalation Device Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 63. APAC Dry Powder Inhalation Device Sales Forecast by Region (2027-2032) & (K Units)
Table 64. APAC Dry Powder Inhalation Device Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 65. Europe Dry Powder Inhalation Device Sales Forecast by Country (2027-2032) & (K Units)
Table 66. Europe Dry Powder Inhalation Device Revenue Forecast by Country (2027-2032) & ($ millions)
Table 67. Middle East & Africa Dry Powder Inhalation Device Sales Forecast by Country (2027-2032) & (K Units)
Table 68. Middle East & Africa Dry Powder Inhalation Device Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Global Dry Powder Inhalation Device Sales Forecast by Type (2027-2032) & (K Units)
Table 70. Global Dry Powder Inhalation Device Revenue Forecast by Type (2027-2032) & ($ millions)
Table 71. Global Dry Powder Inhalation Device Sales Forecast by Application (2027-2032) & (K Units)
Table 72. Global Dry Powder Inhalation Device Revenue Forecast by Application (2027-2032) & ($ millions)
Table 73. Catalent Basic Information, Dry Powder Inhalation Device Manufacturing Base, Sales Area and Its Competitors
Table 74. Catalent Dry Powder Inhalation Device Product Portfolios and Specifications
Table 75. Catalent Dry Powder Inhalation Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 76. Catalent Main Business
Table 77. Catalent Latest Developments
Table 78. AptarGroup Basic Information, Dry Powder Inhalation Device Manufacturing Base, Sales Area and Its Competitors
Table 79. AptarGroup Dry Powder Inhalation Device Product Portfolios and Specifications
Table 80. AptarGroup Dry Powder Inhalation Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 81. AptarGroup Main Business
Table 82. AptarGroup Latest Developments
Table 83. H&T Presspart Basic Information, Dry Powder Inhalation Device Manufacturing Base, Sales Area and Its Competitors
Table 84. H&T Presspart Dry Powder Inhalation Device Product Portfolios and Specifications
Table 85. H&T Presspart Dry Powder Inhalation Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 86. H&T Presspart Main Business
Table 87. H&T Presspart Latest Developments
Table 88. Vectura Delivery Devices Basic Information, Dry Powder Inhalation Device Manufacturing Base, Sales Area and Its Competitors
Table 89. Vectura Delivery Devices Dry Powder Inhalation Device Product Portfolios and Specifications
Table 90. Vectura Delivery Devices Dry Powder Inhalation Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 91. Vectura Delivery Devices Main Business
Table 92. Vectura Delivery Devices Latest Developments
Table 93. MannKind Corporation Basic Information, Dry Powder Inhalation Device Manufacturing Base, Sales Area and Its Competitors
Table 94. MannKind Corporation Dry Powder Inhalation Device Product Portfolios and Specifications
Table 95. MannKind Corporation Dry Powder Inhalation Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 96. MannKind Corporation Main Business
Table 97. MannKind Corporation Latest Developments
Table 98. MicroDose Therapeutx Basic Information, Dry Powder Inhalation Device Manufacturing Base, Sales Area and Its Competitors
Table 99. MicroDose Therapeutx Dry Powder Inhalation Device Product Portfolios and Specifications
Table 100. MicroDose Therapeutx Dry Powder Inhalation Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 101. MicroDose Therapeutx Main Business
Table 102. MicroDose Therapeutx Latest Developments
Table 103. GSK Basic Information, Dry Powder Inhalation Device Manufacturing Base, Sales Area and Its Competitors
Table 104. GSK Dry Powder Inhalation Device Product Portfolios and Specifications
Table 105. GSK Dry Powder Inhalation Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 106. GSK Main Business
Table 107. GSK Latest Developments
Table 108. Novartis Basic Information, Dry Powder Inhalation Device Manufacturing Base, Sales Area and Its Competitors
Table 109. Novartis Dry Powder Inhalation Device Product Portfolios and Specifications
Table 110. Novartis Dry Powder Inhalation Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 111. Novartis Main Business
Table 112. Novartis Latest Developments
Table 113. AstraZeneca Basic Information, Dry Powder Inhalation Device Manufacturing Base, Sales Area and Its Competitors
Table 114. AstraZeneca Dry Powder Inhalation Device Product Portfolios and Specifications
Table 115. AstraZeneca Dry Powder Inhalation Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 116. AstraZeneca Main Business
Table 117. AstraZeneca Latest Developments
Table 118. Boehringer Ingelheim Basic Information, Dry Powder Inhalation Device Manufacturing Base, Sales Area and Its Competitors
Table 119. Boehringer Ingelheim Dry Powder Inhalation Device Product Portfolios and Specifications
Table 120. Boehringer Ingelheim Dry Powder Inhalation Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 121. Boehringer Ingelheim Main Business
Table 122. Boehringer Ingelheim Latest Developments
Table 123. Orion Pharma Basic Information, Dry Powder Inhalation Device Manufacturing Base, Sales Area and Its Competitors
Table 124. Orion Pharma Dry Powder Inhalation Device Product Portfolios and Specifications
Table 125. Orion Pharma Dry Powder Inhalation Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 126. Orion Pharma Main Business
Table 127. Orion Pharma Latest Developments
Table 128. ?Liquidia Technologies? Basic Information, Dry Powder Inhalation Device Manufacturing Base, Sales Area and Its Competitors
Table 129. ?Liquidia Technologies? Dry Powder Inhalation Device Product Portfolios and Specifications
Table 130. ?Liquidia Technologies? Dry Powder Inhalation Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 131. ?Liquidia Technologies? Main Business
Table 132. ?Liquidia Technologies? Latest Developments
Table 133. ?Teva Pharmaceutical Industries? Basic Information, Dry Powder Inhalation Device Manufacturing Base, Sales Area and Its Competitors
Table 134. ?Teva Pharmaceutical Industries? Dry Powder Inhalation Device Product Portfolios and Specifications
Table 135. ?Teva Pharmaceutical Industries? Dry Powder Inhalation Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 136. ?Teva Pharmaceutical Industries? Main Business
Table 137. ?Teva Pharmaceutical Industries? Latest Developments
Table 138. Chiesi?? Basic Information, Dry Powder Inhalation Device Manufacturing Base, Sales Area and Its Competitors
Table 139. Chiesi?? Dry Powder Inhalation Device Product Portfolios and Specifications
Table 140. Chiesi?? Dry Powder Inhalation Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 141. Chiesi?? Main Business
Table 142. Chiesi?? Latest Developments
Table 143. Hovione Basic Information, Dry Powder Inhalation Device Manufacturing Base, Sales Area and Its Competitors
Table 144. Hovione Dry Powder Inhalation Device Product Portfolios and Specifications
Table 145. Hovione Dry Powder Inhalation Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 146. Hovione Main Business
Table 147. Hovione Latest Developments
Table 148. Nemera Basic Information, Dry Powder Inhalation Device Manufacturing Base, Sales Area and Its Competitors
Table 149. Nemera Dry Powder Inhalation Device Product Portfolios and Specifications
Table 150. Nemera Dry Powder Inhalation Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 151. Nemera Main Business
Table 152. Nemera Latest Developments
Table 153. D?rr Basic Information, Dry Powder Inhalation Device Manufacturing Base, Sales Area and Its Competitors
Table 154. D?rr Dry Powder Inhalation Device Product Portfolios and Specifications
Table 155. D?rr Dry Powder Inhalation Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 156. D?rr Main Business
Table 157. D?rr Latest Developments
Table 158. Shanghai Huarui Basic Information, Dry Powder Inhalation Device Manufacturing Base, Sales Area and Its Competitors
Table 159. Shanghai Huarui Dry Powder Inhalation Device Product Portfolios and Specifications
Table 160. Shanghai Huarui Dry Powder Inhalation Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 161. Shanghai Huarui Main Business
Table 162. Shanghai Huarui Latest Developments
Table 163. Hangzhou Changxi Pharmaceutical Basic Information, Dry Powder Inhalation Device Manufacturing Base, Sales Area and Its Competitors
Table 164. Hangzhou Changxi Pharmaceutical Dry Powder Inhalation Device Product Portfolios and Specifications
Table 165. Hangzhou Changxi Pharmaceutical Dry Powder Inhalation Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 166. Hangzhou Changxi Pharmaceutical Main Business
Table 167. Hangzhou Changxi Pharmaceutical Latest Developments
Table 168. Suzhou Inha Medicine Basic Information, Dry Powder Inhalation Device Manufacturing Base, Sales Area and Its Competitors
Table 169. Suzhou Inha Medicine Dry Powder Inhalation Device Product Portfolios and Specifications
Table 170. Suzhou Inha Medicine Dry Powder Inhalation Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 171. Suzhou Inha Medicine Main Business
Table 172. Suzhou Inha Medicine Latest Developments
Table 173. Shenzhen Resproly Biopharmaceuticals Basic Information, Dry Powder Inhalation Device Manufacturing Base, Sales Area and Its Competitors
Table 174. Shenzhen Resproly Biopharmaceuticals Dry Powder Inhalation Device Product Portfolios and Specifications
Table 175. Shenzhen Resproly Biopharmaceuticals Dry Powder Inhalation Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 176. Shenzhen Resproly Biopharmaceuticals Main Business
Table 177. Shenzhen Resproly Biopharmaceuticals Latest Developments
LIST OF FIGURES
Figure 1. Picture of Dry Powder Inhalation Device
Figure 2. Dry Powder Inhalation Device Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Dry Powder Inhalation Device Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Dry Powder Inhalation Device Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Dry Powder Inhalation Device Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Dry Powder Inhalation Device Sales Market Share by Country/Region (2025)
Figure 10. Dry Powder Inhalation Device Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Single Dose
Figure 12. Product Picture of Multiple Doses
Figure 13. Product Picture of Storage Type
Figure 14. Global Dry Powder Inhalation Device Sales Market Share by Type in 2026
Figure 15. Global Dry Powder Inhalation Device Revenue Market Share by Type (2021-2026)
Figure 16. Dry Powder Inhalation Device Consumed in Asthmatic
Figure 17. Global Dry Powder Inhalation Device Market: Asthmatic (2021-2026) & (K Units)
Figure 18. Dry Powder Inhalation Device Consumed in COPD
Figure 19. Global Dry Powder Inhalation Device Market: COPD (2021-2026) & (K Units)
Figure 20. Dry Powder Inhalation Device Consumed in Other
Figure 21. Global Dry Powder Inhalation Device Market: Other (2021-2026) & (K Units)
Figure 22. Global Dry Powder Inhalation Device Sale Market Share by Application (2025)
Figure 23. Global Dry Powder Inhalation Device Revenue Market Share by Application in 2026
Figure 24. Dry Powder Inhalation Device Sales by Company in 2026 (K Units)
Figure 25. Global Dry Powder Inhalation Device Sales Market Share by Company in 2026
Figure 26. Dry Powder Inhalation Device Revenue by Company in 2026 ($ millions)
Figure 27. Global Dry Powder Inhalation Device Revenue Market Share by Company in 2026
Figure 28. Global Dry Powder Inhalation Device Sales Market Share by Geographic Region (2021-2026)
Figure 29. Global Dry Powder Inhalation Device Revenue Market Share by Geographic Region in 2026
Figure 30. Americas Dry Powder Inhalation Device Sales 2021-2026 (K Units)
Figure 31. Americas Dry Powder Inhalation Device Revenue 2021-2026 ($ millions)
Figure 32. APAC Dry Powder Inhalation Device Sales 2021-2026 (K Units)
Figure 33. APAC Dry Powder Inhalation Device Revenue 2021-2026 ($ millions)
Figure 34. Europe Dry Powder Inhalation Device Sales 2021-2026 (K Units)
Figure 35. Europe Dry Powder Inhalation Device Revenue 2021-2026 ($ millions)
Figure 36. Middle East & Africa Dry Powder Inhalation Device Sales 2021-2026 (K Units)
Figure 37. Middle East & Africa Dry Powder Inhalation Device Revenue 2021-2026 ($ millions)
Figure 38. Americas Dry Powder Inhalation Device Sales Market Share by Country in 2026
Figure 39. Americas Dry Powder Inhalation Device Revenue Market Share by Country (2021-2026)
Figure 40. Americas Dry Powder Inhalation Device Sales Market Share by Type (2021-2026)
Figure 41. Americas Dry Powder Inhalation Device Sales Market Share by Application (2021-2026)
Figure 42. United States Dry Powder Inhalation Device Revenue Growth 2021-2026 ($ millions)
Figure 43. Canada Dry Powder Inhalation Device Revenue Growth 2021-2026 ($ millions)
Figure 44. Mexico Dry Powder Inhalation Device Revenue Growth 2021-2026 ($ millions)
Figure 45. Brazil Dry Powder Inhalation Device Revenue Growth 2021-2026 ($ millions)
Figure 46. APAC Dry Powder Inhalation Device Sales Market Share by Region in 2026
Figure 47. APAC Dry Powder Inhalation Device Revenue Market Share by Region (2021-2026)
Figure 48. APAC Dry Powder Inhalation Device Sales Market Share by Type (2021-2026)
Figure 49. APAC Dry Powder Inhalation Device Sales Market Share by Application (2021-2026)
Figure 50. China Dry Powder Inhalation Device Revenue Growth 2021-2026 ($ millions)
Figure 51. Japan Dry Powder Inhalation Device Revenue Growth 2021-2026 ($ millions)
Figure 52. South Korea Dry Powder Inhalation Device Revenue Growth 2021-2026 ($ millions)
Figure 53. Southeast Asia Dry Powder Inhalation Device Revenue Growth 2021-2026 ($ millions)
Figure 54. India Dry Powder Inhalation Device Revenue Growth 2021-2026 ($ millions)
Figure 55. Australia Dry Powder Inhalation Device Revenue Growth 2021-2026 ($ millions)
Figure 56. China Taiwan Dry Powder Inhalation Device Revenue Growth 2021-2026 ($ millions)
Figure 57. Europe Dry Powder Inhalation Device Sales Market Share by Country in 2026
Figure 58. Europe Dry Powder Inhalation Device Revenue Market Share by Country (2021-2026)
Figure 59. Europe Dry Powder Inhalation Device Sales Market Share by Type (2021-2026)
Figure 60. Europe Dry Powder Inhalation Device Sales Market Share by Application (2021-2026)
Figure 61. Germany Dry Powder Inhalation Device Revenue Growth 2021-2026 ($ millions)
Figure 62. France Dry Powder Inhalation Device Revenue Growth 2021-2026 ($ millions)
Figure 63. UK Dry Powder Inhalation Device Revenue Growth 2021-2026 ($ millions)
Figure 64. Italy Dry Powder Inhalation Device Revenue Growth 2021-2026 ($ millions)
Figure 65. Russia Dry Powder Inhalation Device Revenue Growth 2021-2026 ($ millions)
Figure 66. Middle East & Africa Dry Powder Inhalation Device Sales Market Share by Country (2021-2026)
Figure 67. Middle East & Africa Dry Powder Inhalation Device Sales Market Share by Type (2021-2026)
Figure 68. Middle East & Africa Dry Powder Inhalation Device Sales Market Share by Application (2021-2026)
Figure 69. Egypt Dry Powder Inhalation Device Revenue Growth 2021-2026 ($ millions)
Figure 70. South Africa Dry Powder Inhalation Device Revenue Growth 2021-2026 ($ millions)
Figure 71. Israel Dry Powder Inhalation Device Revenue Growth 2021-2026 ($ millions)
Figure 72. Turkey Dry Powder Inhalation Device Revenue Growth 2021-2026 ($ millions)
Figure 73. GCC Countries Dry Powder Inhalation Device Revenue Growth 2021-2026 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of Dry Powder Inhalation Device in 2026
Figure 75. Manufacturing Process Analysis of Dry Powder Inhalation Device
Figure 76. Industry Chain Structure of Dry Powder Inhalation Device
Figure 77. Channels of Distribution
Figure 78. Global Dry Powder Inhalation Device Sales Market Forecast by Region (2027-2032)
Figure 79. Global Dry Powder Inhalation Device Revenue Market Share Forecast by Region (2027-2032)
Figure 80. Global Dry Powder Inhalation Device Sales Market Share Forecast by Type (2027-2032)
Figure 81. Global Dry Powder Inhalation Device Revenue Market Share Forecast by Type (2027-2032)
Figure 82. Global Dry Powder Inhalation Device Sales Market Share Forecast by Application (2027-2032)
Figure 83. Global Dry Powder Inhalation Device Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Dry Powder Inhalation Device
Figure 2. Dry Powder Inhalation Device Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Dry Powder Inhalation Device Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Dry Powder Inhalation Device Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Dry Powder Inhalation Device Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Dry Powder Inhalation Device Sales Market Share by Country/Region (2025)
Figure 10. Dry Powder Inhalation Device Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Single Dose
Figure 12. Product Picture of Multiple Doses
Figure 13. Product Picture of Storage Type
Figure 14. Global Dry Powder Inhalation Device Sales Market Share by Type in 2026
Figure 15. Global Dry Powder Inhalation Device Revenue Market Share by Type (2021-2026)
Figure 16. Dry Powder Inhalation Device Consumed in Asthmatic
Figure 17. Global Dry Powder Inhalation Device Market: Asthmatic (2021-2026) & (K Units)
Figure 18. Dry Powder Inhalation Device Consumed in COPD
Figure 19. Global Dry Powder Inhalation Device Market: COPD (2021-2026) & (K Units)
Figure 20. Dry Powder Inhalation Device Consumed in Other
Figure 21. Global Dry Powder Inhalation Device Market: Other (2021-2026) & (K Units)
Figure 22. Global Dry Powder Inhalation Device Sale Market Share by Application (2025)
Figure 23. Global Dry Powder Inhalation Device Revenue Market Share by Application in 2026
Figure 24. Dry Powder Inhalation Device Sales by Company in 2026 (K Units)
Figure 25. Global Dry Powder Inhalation Device Sales Market Share by Company in 2026
Figure 26. Dry Powder Inhalation Device Revenue by Company in 2026 ($ millions)
Figure 27. Global Dry Powder Inhalation Device Revenue Market Share by Company in 2026
Figure 28. Global Dry Powder Inhalation Device Sales Market Share by Geographic Region (2021-2026)
Figure 29. Global Dry Powder Inhalation Device Revenue Market Share by Geographic Region in 2026
Figure 30. Americas Dry Powder Inhalation Device Sales 2021-2026 (K Units)
Figure 31. Americas Dry Powder Inhalation Device Revenue 2021-2026 ($ millions)
Figure 32. APAC Dry Powder Inhalation Device Sales 2021-2026 (K Units)
Figure 33. APAC Dry Powder Inhalation Device Revenue 2021-2026 ($ millions)
Figure 34. Europe Dry Powder Inhalation Device Sales 2021-2026 (K Units)
Figure 35. Europe Dry Powder Inhalation Device Revenue 2021-2026 ($ millions)
Figure 36. Middle East & Africa Dry Powder Inhalation Device Sales 2021-2026 (K Units)
Figure 37. Middle East & Africa Dry Powder Inhalation Device Revenue 2021-2026 ($ millions)
Figure 38. Americas Dry Powder Inhalation Device Sales Market Share by Country in 2026
Figure 39. Americas Dry Powder Inhalation Device Revenue Market Share by Country (2021-2026)
Figure 40. Americas Dry Powder Inhalation Device Sales Market Share by Type (2021-2026)
Figure 41. Americas Dry Powder Inhalation Device Sales Market Share by Application (2021-2026)
Figure 42. United States Dry Powder Inhalation Device Revenue Growth 2021-2026 ($ millions)
Figure 43. Canada Dry Powder Inhalation Device Revenue Growth 2021-2026 ($ millions)
Figure 44. Mexico Dry Powder Inhalation Device Revenue Growth 2021-2026 ($ millions)
Figure 45. Brazil Dry Powder Inhalation Device Revenue Growth 2021-2026 ($ millions)
Figure 46. APAC Dry Powder Inhalation Device Sales Market Share by Region in 2026
Figure 47. APAC Dry Powder Inhalation Device Revenue Market Share by Region (2021-2026)
Figure 48. APAC Dry Powder Inhalation Device Sales Market Share by Type (2021-2026)
Figure 49. APAC Dry Powder Inhalation Device Sales Market Share by Application (2021-2026)
Figure 50. China Dry Powder Inhalation Device Revenue Growth 2021-2026 ($ millions)
Figure 51. Japan Dry Powder Inhalation Device Revenue Growth 2021-2026 ($ millions)
Figure 52. South Korea Dry Powder Inhalation Device Revenue Growth 2021-2026 ($ millions)
Figure 53. Southeast Asia Dry Powder Inhalation Device Revenue Growth 2021-2026 ($ millions)
Figure 54. India Dry Powder Inhalation Device Revenue Growth 2021-2026 ($ millions)
Figure 55. Australia Dry Powder Inhalation Device Revenue Growth 2021-2026 ($ millions)
Figure 56. China Taiwan Dry Powder Inhalation Device Revenue Growth 2021-2026 ($ millions)
Figure 57. Europe Dry Powder Inhalation Device Sales Market Share by Country in 2026
Figure 58. Europe Dry Powder Inhalation Device Revenue Market Share by Country (2021-2026)
Figure 59. Europe Dry Powder Inhalation Device Sales Market Share by Type (2021-2026)
Figure 60. Europe Dry Powder Inhalation Device Sales Market Share by Application (2021-2026)
Figure 61. Germany Dry Powder Inhalation Device Revenue Growth 2021-2026 ($ millions)
Figure 62. France Dry Powder Inhalation Device Revenue Growth 2021-2026 ($ millions)
Figure 63. UK Dry Powder Inhalation Device Revenue Growth 2021-2026 ($ millions)
Figure 64. Italy Dry Powder Inhalation Device Revenue Growth 2021-2026 ($ millions)
Figure 65. Russia Dry Powder Inhalation Device Revenue Growth 2021-2026 ($ millions)
Figure 66. Middle East & Africa Dry Powder Inhalation Device Sales Market Share by Country (2021-2026)
Figure 67. Middle East & Africa Dry Powder Inhalation Device Sales Market Share by Type (2021-2026)
Figure 68. Middle East & Africa Dry Powder Inhalation Device Sales Market Share by Application (2021-2026)
Figure 69. Egypt Dry Powder Inhalation Device Revenue Growth 2021-2026 ($ millions)
Figure 70. South Africa Dry Powder Inhalation Device Revenue Growth 2021-2026 ($ millions)
Figure 71. Israel Dry Powder Inhalation Device Revenue Growth 2021-2026 ($ millions)
Figure 72. Turkey Dry Powder Inhalation Device Revenue Growth 2021-2026 ($ millions)
Figure 73. GCC Countries Dry Powder Inhalation Device Revenue Growth 2021-2026 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of Dry Powder Inhalation Device in 2026
Figure 75. Manufacturing Process Analysis of Dry Powder Inhalation Device
Figure 76. Industry Chain Structure of Dry Powder Inhalation Device
Figure 77. Channels of Distribution
Figure 78. Global Dry Powder Inhalation Device Sales Market Forecast by Region (2027-2032)
Figure 79. Global Dry Powder Inhalation Device Revenue Market Share Forecast by Region (2027-2032)
Figure 80. Global Dry Powder Inhalation Device Sales Market Share Forecast by Type (2027-2032)
Figure 81. Global Dry Powder Inhalation Device Revenue Market Share Forecast by Type (2027-2032)
Figure 82. Global Dry Powder Inhalation Device Sales Market Share Forecast by Application (2027-2032)
Figure 83. Global Dry Powder Inhalation Device Revenue Market Share Forecast by Application (2027-2032)
